methylprednisolone and Calcinosis-Raynaud Phenomenon-Sclerodactyly-Telangiectasia

methylprednisolone has been researched along with Calcinosis-Raynaud Phenomenon-Sclerodactyly-Telangiectasia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brandão-Neto, RA; Ramos, RG; Santana, AN; Zanandrea, EF1
Aguilar, JL; Avalos-Díaz, E; González, I; Herrera-Esparza, R; López-Robles, E; Saucedo, A1

Other Studies

2 other study(ies) available for methylprednisolone and Calcinosis-Raynaud Phenomenon-Sclerodactyly-Telangiectasia

ArticleYear
Bone marrow necrosis successfully treated with corticosteroid.
    European journal of haematology, 2005, Volume: 74, Issue:1

    Topics: Adrenal Cortex Hormones; Bone Marrow; CREST Syndrome; Esophageal and Gastric Varices; Female; Humans; Hypertension, Portal; Methylprednisolone; Middle Aged; Necrosis; Prednisone

2005
Scleroderma with type III glomerulonephritis and MPO-ANCA antibodies in the serum.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2005, Volume: 19, Issue:5

    Topics: Antibodies, Antineutrophil Cytoplasmic; Biopsy, Needle; CREST Syndrome; Cyclophosphamide; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique, Indirect; Follow-Up Studies; Glomerulonephritis, IGA; Humans; Immunohistochemistry; Methylprednisolone; Middle Aged; Peroxidase; Risk Assessment; Scleroderma, Systemic; Severity of Illness Index; Treatment Outcome

2005